WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck
PHASE1
This phase I trial studies the side effects and the best dose of WEE1 inhib...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
PHASE3
This is an international, multicenter, open-label, randomized, Phase 3 stud...
Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients.
PHASE2
Clinical trial phase I / II, prospective, multicenter, open, randomized, pa...
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
PHASE3
This phase III trial is studying vincristine, dactinomycin, and doxorubicin...